The first Renal & Hepatic Network The Network has conducted over 620 Renal and Hepatic protocols Established in 2000 |
The first Renal & Hepatic Network The Network has conducted over 620 Renal and Hepatic protocols Established in 2000 |
|
The U.S. Renal Network provides sponsors access to the largest database of Renal and Hepatic patients (mild, moderate and severe), in conducting Phase I-II clinical trials. The U.S. Renal Network trial sites have experience and knowledge with specialty populations in conducting these types of studies. We understand Cockcroft Gault and MDRD as it relates to the 1998 FDA Guidelines for Renal studies and the 2010 proposed FDA Guidelines for Renal studies to make your study successful. We presented at ASN in 2010 data on renal subjects enrolled in the network and our findings as it relates to eGFR with C.G. and MDRD ( Click here to view the abstract ). As a network we offer sponsors rapid start up with regulatory documents and legal agreements (less than 21 days) and enroll subjects rapidly, less than half to one-third of the time of single site, delivering quality data in an advantageous timeframe.
The U.S. Renal Network's success has been achieved by working together for over 10 years. Each site has clinical staff that is knowledgeable and experienced in recruiting and enrolling specialty population subjects. We have successfully completed hundreds of Renal and Hepatic studies. The Network is collaborative and competitive, working together to coordinate enrollment of subjects and their matches between all sites, to assure the study timelines are met.
| New Orleans Center for Clinical Research | DaVita Clinical Research | Orlando Clinical Research Center |
|
1928 Alcoa Highway Phone 865 305-9100 x246 |
825 S. 8th Street Suite 300 Minneapolis, MN 55404 Phone 612 618 1002 |
5055 South Orange Avenue Orlando, Florida 32809 Phone: 407.240.7878 |
| Bill Smith M.D. | Harry Alcorn Jr. Pharm.D. | Tom Marbury M.D. |
| www.noccr.com |
www.davitaclinicalresearch.com
|
www.ocrc.net |
Additional Information: Please contact:
Harry Alcorn Jr. Pharm. D.
Phone (612) 618 1002
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH RENAL HEPATIC RESEARCH
